Viewing StudyNCT02245737



Ignite Creation Date: 2024-05-06 @ 3:15 AM
Last Modification Date: 2024-10-26 @ 11:30 AM
Study NCT ID: NCT02245737
Status: TERMINATED
Last Update Posted: 2019-12-03
First Post: 2014-09-18

Brief Title: An Efficacy and Safety Study of Lanabecestat LY3314814 in Early Alzheimers Disease
Sponsor: AstraZeneca
Organization: AstraZeneca

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-09-30
Start Date Type: ACTUAL
Primary Completion Date: 2018-10-04
Primary Completion Date Type: ACTUAL
Completion Date: 2018-10-04
Completion Date Type: ACTUAL
First Submit Date: 2014-09-18
First Submit QC Date: September 18 2014
Study First Post Date: 2014-09-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2019-08-06
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-11-19
Last Update Post Date: 2019-12-03
Last Update Post Date Type: ACTUAL